Beckley adds digital element to its psychedelic drug trials
pharmaphorum
MAY 19, 2022
Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies for patient monitoring, thanks to a new partnership with Empatica. Eventually, it intends to layer in digital monitoring as a fundamental component in the development of all its psychedelic-assisted psychotherapy programmes.
Let's personalize your content